Skip to content

Infant Formula and Toddler Drink Feeding Intervention

Infant Formula and Toddler Drink Feeding Intervention Through 24 Months of Age

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04495738
Enrollment
168
Registered
2020-08-03
Start date
2020-08-10
Completion date
2021-04-12
Last updated
2021-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Infections in Children

Brief summary

The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.

Interventions

Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age

16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age

Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age

16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age

OTHERSupplemental Formula for HM Group

Ad libitum formula given up to 12 months of age if HM is supplemented

OTHERToddler Drink for HM group

16 fl oz per day if weaned from HM feedings

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Days
Healthy volunteers
Yes

Inclusion criteria

* Participant is judged to be in good health as determined from participant's medical history * Participant is a singleton from a full-term birth with a gestational age of 37 - 42 weeks * Participant's birth weight was ≥ 2490 g (\ 5 lbs. 8 oz.) * If parent(s) elect to formula feed the participant they confirm their intention to feed their participant the study product as the sole source of feeding until 4 months of age, and as the sole milk beverage during the first 12 months of life * If parent(s) elect to formula feed the participant, they confirm their intention to feed the participant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage * If parent(s) elect to feed the participant mother's human milk, they confirm that their infant was exclusively fed mother's human milk since birth and confirm their intention to continue exclusively feeding human milk as the sole source of feeding through 4 months of age * If parent(s) of human milk fed participant elect to supplement or wean after 4 months to 24 months of age, they confirm their intention to use the supplemental/weaning formula or toddler drink as the primary milk beverage * Parent(s) of formula-fed participant confirm their intention not to administer vitamin or mineral supplements, from enrollment through the duration of the study * Parent(s) confirm their intention not to administer solid foods or juices to the participant from enrollment through 6 months of age * Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.

Exclusion criteria

* An adverse maternal, fetal or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development * Participant is taking and plans to continue medications (including over the counter (OTC), home remedies, herbal preparations, prebiotics or probiotics, or rehydration fluids that might affect GI tolerance * Participant is in another study that has not been approved as a concomitant study * Participant has been treated with antibiotics prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Incidence of respiratory infection between study groupsStudy Day 1 to 6 Months of AgeAdverse event reports

Secondary

MeasureTime frameDescription
Infection morbidity between study groupsStudy Day 1 to 24 Months of AgeAdverse event reports

Other

MeasureTime frameDescription
LengthStudy Day 1 to 24 Months of AgeLength in cm
Head Circumference (HC)Study Day 1 to 24 Months of AgeHC in cm
Gastrointestinal ToleranceStudy Day 1 to 119 Days of AgeParent completed diary
Dietary IntakeStudy Day 1 to 24 Months of AgeParent completed diary
Infant Feeding and Stool Patterns Questionnaire28 Days of Age to 119 Days of AgeParent completed questionnaire; 16, 5-point Likert scale questions, scaled in the negative direction
Infant Behavior Questionnaire119 Days of AgeParent completed questionnaire; 22 questions with 5-point Likert scale questions, scaled in the negative direction
Toddler Drink Satisfaction Questionnaire15 Months of Age to 24 Months of AgeParent completed questionnaire; 12 questions with 5-point Likert scale questions scaled in the negative direction
Human Milk Sample84 Days of AgeOligosaccharide characterization
Stool SampleStudy Day 1 to 24 Months of AgeMicrobiota characterization
Formula Satisfaction Questionnaire28 Days of Age to 6 Months of AgeParent completed questionnaire; 12 questions with 5-point Likert scale questions scaled in the negative direction
Modified Home Short Form6 Months of Age to 24 Months of AgeParent completed questionnaire; 8 questions related to the home environment adapted from the HSF compared between groups
Behavioral Questionnaire12 Months of Age to 24 Months of AgeParent completed questionnaire; 8 questions related to sleep, physical activity and screen time
Ages & Stages Questionnaire6 Months of Age to 18 Months of AgeParent completed questionnaire; 5 Developmental areas; Scores to the six questions in each area are totaled; Higher scores indicate more positive outcomes
Bayley Scale of Infant & Toddler Development12 Months of Age to 24 Months of AgeExaminer rated assessment; Scores are totaled and compared to normative age group data and between groups
MacArthur Communicative Developmental Inventory12 Months of Age to 24 Months of AgeParent completed questionnaire of Words and Gestures and Words and Sentences; Percentiles compared to normative group data and between groups
Edinburgh Postnatal Depression Scale28 Days of AgeMother completed questionnaire; Scores for each of the 10 items are totaled; Higher scores indicate more depressive symptoms
MedicationsStudy Day 1 to 24 Months of AgeMedication usage including frequency and reason for use
Adverse EventsStudy Day 1 to 24 Months of AgeStandard Adverse Event reporting
Health Resource UtilizationStudy Day 1 to 24 Months of AgeNumber of visits
Saliva Sample84 Days of AgeMaternal-Infant secretor status
WeightStudy Day 1 to 24 Months of AgeWeight in grams

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026